ADC Therapeutics SA - Common Shares (ADCT)

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Shares
Shares outstanding: 124,058,172
Number of holders: 41
Total 13F shares, excl. options: 21,557,623
Shares change: +21,557,623
Total reported value, excl. options: $1,000,339,109
Value change: +$1,000,339,111
Number of buys: 41
Price: $46.81

Significant Holders of ADC Therapeutics SA - Common Shares (ADCT) as of Q2 2020

41 filings reported holding ADCT - ADC Therapeutics SA - Common Shares as of Q2 2020.
ADC Therapeutics SA - Common Shares (ADCT) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 21,557,623 shares of 124,058,172 outstanding shares and own 17.38% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (5,525,870 shares), FMR LLC (5,244,231 shares), BAKER BROS. ADVISORS LP (1,687,500 shares), Magnetar Financial LLC (1,563,438 shares), Grosvenor Holdings, L.L.C. (1,277,212 shares), JPMORGAN CHASE & CO (1,142,773 shares), ALLIANCEBERNSTEIN L.P. (927,577 shares), PRICE T ROWE ASSOCIATES INC /MD/ (592,251 shares), MPM Oncology Impact Management LP (539,648 shares), and HILLHOUSE CAPITAL ADVISORS, LTD. (500,000 shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.